You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table GPS-17. Lifetime prevalence of drug use among the age group of 15 to 24 years old in nationwide surveys among the general population. Last survey available for each Member State

Country	Geographical Area	Year	Ref.	Age range (15-24)	Sample size 15-24	Cannabis (%)	Cocaine (%) (1)	Amphet-amines (%) (2)	Ecstasy (%) (3)	LSD (%)
Belgium	National	2004	(6)	15-24		22.3
Bulgaria	National	2005	(1)	18-24	173	13.5	3.8	4.4	3.8	2.7
Czech Republic	National	2004	(2)	18-24	586	43.9	2.1	4.9	18.7	3.7
Denmark	National	2005	(4)	16-24	1434	44.2	8.0	11.2	5.5	1.8
Germany	National	2003	(6)	18-24	1891	43.0	4.7	6.0	6.3	3.3
Estonia	National	2003	(2)	15-24	329
Ireland	National	2002-03	(4)	15-24		22.8	5.1	4.4	7.7	3.9
Greece	National (except Aegean and Ionian Islands)	2004	(3)	15-24	1 785	9.0	0.6	0.2	0.4	0.5
Spain	National	2005-06	(6)	15-24	8188	38.9	8.7	4.9	6.9
France	National	2005	(6)	15-24	4662	42.0	2.5	0.8	3.0	0.8
Italy	National	2005	(3)	15-24	9006	32.6	5.7	1.7	2.5	3.5
Cyprus	National	2006	(1)	15-24	969	6.9	1.4	0.9	2.1	0.9
Latvia	National	2003	(1)	15-24		22.9	1.4	6.0	6.2	2.8
Lithuania	National	2004	(1)	15-24	923	15.7	0.7	2.6	2.6	0.7
Luxembourg	National	1998	(1)	15-24		16.1	0.5		2.3	1.8
Hungary	National	2003	(2)	18-24	943	25.3	1.4	5.9	7.9	4.2
Malta	National	2001	(1)	18-24	287	4.9	1.1	1.1	1.7	1.6
Netherlands	National	2005	(3)	15-24		28.3	2.8	2.0	5.1	0.7
Austria	National	2004	(1)	15-24	959	29.7	2.9	3.7	5.2	1.8
Poland	National	2002	(1)	16-24		18.6	1.8	5.2	2.2	3.5
Portugal	National	2001	(1)	15-24	3099	12.2	1.1	0.4	1.8	0.7
Romania	National	2004	(1)	15-24		2.7	0.4	0.3	0.8	0.0
Slovakia	National	2004	(2)	15-24	307	29.6	1.0	1.3	7.8
Finland	National	2004	(6)	15-24	494	21.2	2.2	3.7	3.3	1.3
Sweden	National	2006	(7)	16-24	7014	15.4
UK	England and Wales	2005-06	(9)	16-24	5892	40.1	10.8	11.3	10.4	3.7
UK	Northern Ireland	2002-03	(10)	15-24		24.0	2.6	6.5	10.2	5.9
UK	Scotland	2004	(12)	16-24	330	33.9	5.6	10.3	7.0	3.8
UK	United Kingdom	2004	(13)			40.4	9.0	12.3	11.0	4.5
Norway	National	2004	(2)	15-24	645	23.4	3.4	5.3	3.4	0.8

Notes:

(1) Cocaine any form.

(2) For Belgium National 2001 and for Metropolitan France 1995: amphetamine and ecstasy, for Denmark National 1994: hard drugs.

(3) For Spain: ecstasy and other designer drugs.

This table aims to present an overview of national surveys. Exceptionally, some relevant regional surveys are presented. Some city surveys reported by countries were not included as they tend to produce higher prevalence estimates which are not comparable with estimates for whole countries (or large regions with both urban and rural areas). Athens was included as reference point for the 1993 survey.

In surveys with small sample sizes results should be interpreted with caution.

Countries were asked to report results using, as far as possible, EMCDDA standard age groups (all adults: 15-64, young adults: 15-34). In countries where age ranges are more restrictive, prevalence estimates tend to be slightly higher. Some countries have recalculated their prevalence figures using the EMCDDA standard age groups.

For methods and definitions on population surveys in general, see General population surveys of drug use – methods and definitions.

For methods of each survey presented in this table, see Table GPS-1 part (ii).

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

See Table GPS-0.